Literature DB >> 3799661

Kinetics and dynamics of nifedipine after oral and sublingual doses.

R G McAllister.   

Abstract

Nifedipine is frequently administered by the sublingual route to provide rapid onset of intense effect, especially in patients in whom urgent reduction of elevated blood pressure is indicated. Previously available data, however, suggest that peak levels of nifedipine are higher and occur earlier when the drug is administered orally. Results of pharmacodynamic studies show that maximal hypotensive effects occur between 30 and 60 minutes after administration by either route, but that such effects are often achieved earlier when the drug is given orally. Recent work implies that the absorption of nifedipine through the buccal mucosa is poor, if it occurs at all, and that the appearance of nifedipine in plasma requires delivery of the drug to the stomach for active absorption. The small time lag in absorption that may be attributed to the dissolution of the nifedipine capsule may be obviated by biting through the capsule and swallowing the contents; this bite-and-swallow approach to dosing provides the most rapid rise in plasma nifedipine concentrations, and produces peak levels well above those achieved with sublingual administration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799661     DOI: 10.1016/0002-9343(86)90787-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

2.  Sublingual nifedipine in acute severe hypertension.

Authors:  R C Hatton; M L Marcadis
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

3.  Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.

Authors:  L A Bauer; K Murray; J R Horn; K Opheim; J Olsen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

5.  The safety and use of short-acting nifedipine in hospitalized hypertensive children.

Authors:  Verna Yiu; Elaine Orrbine; Rhonda J Rosychuk; Peter MacLaine; Paul Goodyer; Colette Girardin; Manjula Gowrishankar; Malcolm Ogborn; Julian Midgley; Guido Filler; Frances Harley
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

Review 6.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.